{"id":"W2897430921","doi":"10.1056/nejmoa1810858","title":"Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2839,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Olaparib; Medicine; Ovarian cancer; Oncology; Chemotherapy; Internal medicine; Disease; PARP inhibitor; Cancer; Maintenance therapy; Gynecology; Poly ADP ribose polymerase; Polymerase; Biology; Enzyme","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}